Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A-C Baglin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Infectious Diseases|January 7, 1999
Human T cell leukemia virus type I expression in salivary glands of infected patientsF Tangy, M Ossondo, J C Vernant, et al.
La Revue De Medecine Interne|January 1, 1994
[Hyperthyroidism and hypersecretion of chorionic gonadotropin in gastric adenocarcinoma]C Brousse, L Mignot, A C Baglin, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1995
[Primary non-Hodgkin lymphoma of the nasal fossae and sinuses. Apropos of 8 cases]X Lachiver, E Salf, A C Baglin, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[Inflammatory fibroid polyps of the colon]A Aubert, A Cazier, A C Baglin, et al.
European Urology|June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancerT Lebret, V Becette, J M Hervé, et al.
Gastroenterologie Clinique Et Biologique|May 1, 1984
[Diffuse recto-colic malacoplakia: association with cryptogenic colitis and remission following long-term antibiotic therapy]P Le Bourgeois, H R Parlier, H E Gompel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 8, 2013
[Target volumes in cervical lympadenopathies of unknown primary: toward a selective customized approach? On behalf of REFCOR]I Troussier, B Barry, A C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|July 6, 2026
Sinonasal squamous cell carcinoma: REFCOR guidelines for diagnosis, treatment and follow-upB Vérillaud, F Chatelet, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|May 9, 2026
REFCOR guidelines for sinonasal adenocarcinomaL de Gabory, C Monnot, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|February 20, 2026
REFCOR guidelines for sinus and nasal cavity cancerC-H Hassan, A-C Baglin, B Baujat, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Infectious Diseases|January 7, 1999
Human T cell leukemia virus type I expression in salivary glands of infected patientsF Tangy, M Ossondo, J C Vernant, et al.
La Revue De Medecine Interne|January 1, 1994
[Hyperthyroidism and hypersecretion of chorionic gonadotropin in gastric adenocarcinoma]C Brousse, L Mignot, A C Baglin, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1995
[Primary non-Hodgkin lymphoma of the nasal fossae and sinuses. Apropos of 8 cases]X Lachiver, E Salf, A C Baglin, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[Inflammatory fibroid polyps of the colon]A Aubert, A Cazier, A C Baglin, et al.
European Urology|June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancerT Lebret, V Becette, J M Hervé, et al.
Gastroenterologie Clinique Et Biologique|May 1, 1984
[Diffuse recto-colic malacoplakia: association with cryptogenic colitis and remission following long-term antibiotic therapy]P Le Bourgeois, H R Parlier, H E Gompel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 8, 2013
[Target volumes in cervical lympadenopathies of unknown primary: toward a selective customized approach? On behalf of REFCOR]I Troussier, B Barry, A C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|July 6, 2026
Sinonasal squamous cell carcinoma: REFCOR guidelines for diagnosis, treatment and follow-upB Vérillaud, F Chatelet, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|May 9, 2026
REFCOR guidelines for sinonasal adenocarcinomaL de Gabory, C Monnot, A-C Baglin, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|February 20, 2026
REFCOR guidelines for sinus and nasal cavity cancerC-H Hassan, A-C Baglin, B Baujat, et al.
Pageof 2